Phase 1 Chronic Graft Versus Host Disease Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
Chronic Graft Versus Host Disease
Incyte Corporation30 enrolled9 locationsNCT06843408
Recruiting
Phase 1
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
Chronic Graft Versus Host Disease
Stefanie Sarantopoulos, MD, PhD.30 enrolled1 locationNCT06233110
Recruiting
Phase 1
A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease
Chronic Graft Versus Host Disease
Qurient Co., Ltd.18 enrolled8 locationsNCT07138196
Recruiting
Phase 1Phase 2
Gecacitinib for cGVHD: Safety and Efficacy in Patients After ≥2 Lines of Prior Therapy
Chronic Graft Versus Host Disease
Yujun DONG24 enrolled1 locationNCT07012304